The Arcady Group

Turning the science of patient medication adherence into action

  • Who we are
    • About Our Company
    • About Our Founder
    • Our Core Team
    • Partner Organizations
    • Photo Gallery
  • Our Work
  • Global Access
    • Resources
    • Insights
  • Contact Us
  • LinkedIn

July 30, 2019

More adherence support for self-administering TB patients is on the way!

Unitaid and the KNCV Tuberculosis Foundation signed a US$13.9 million grant agreement to enhance the existing evidence base, drive scaled deployment, and create market access plans and tools for digital adherence technologies to enhance TB medication adherence. 

Filed Under: Insights, News Tagged With: ASCENT, Everwell, KNCV, London School of Hygiene & Tropical Medicine, PATH, The Aurum Institute, Unitaid

The Arcady Group

To turn the science of patient medication adherence into action

Resource Formats

  • Scientific Literature
  • Technology Toolkits
  • Conference Presentation
  • Special Report
  • How-to Guides
  • News/Press Release
  • Video
  • Infographic

Insights

  • Announcements
  • Insights
  • Links to Noteworthy
  • Materials Presented
  • Presentations

About Us

  • Our Vision
  • About Our Company
  • How we work
  • About Our Founder
  • Our Core Team
  • Code of Ethics

Illustrative Engagements

  • Illustrative Engagements
  • Medicines for All Institute Initiative
  • Patient Adherence
  • TB Adherence Supply Chain
  • TB Adherence Survey

© Copyright 2019 The Arcady Group · All Rights Reserved · Website Design by Richmond Digital Marketing